Abstract
Introduction
Non-prescribed anabolic-androgenic steroid (AAS) use is widespread and may induce hypogonadism, and metabolic, cardiovascular and mental health risks. The study aims to explore feasibility and safety of off label clomiphene citrate therapy, whether the treatment will...
Abstract
Objective
Symptomatic hypogonadism discourages men from stopping anabolic-androgenic steroids (AAS). Some men illicitly take drugs temporarily stimulating endogenous testosterone following AAS cessation (post-cycle therapy; PCT) to lessen hypogonadal symptoms. We investigated whether...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.